Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase - PubMed (original) (raw)
Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase
A Matsui et al. Cancer Lett. 2000.
Abstract
There is increasing evidence that catecholestrogens may contribute to the development of breast cancer. Specifically, inactivation of catecholestrogens may prevent the genesis and arrest the progression of the disease. Catechol-O-methyltransferase (COMT), Glutathione S-transferase (GST) M1 and GSTP1 are responsible for the detoxification of catecholestrogens, and are polymorphic in the human population. In this study, a PCR-based restriction fragment length polymorphism analysis was performed to determine genotypes of the COMT, GSTM1 and GSTP1 genes. We investigated the relationship between the germline polymorphism of these genes and clinico-pathological characteristics in 140 patients with breast cancer. Among 73 patients with the low activity COMT allele, 49 (67%) had regional lymph node metastasis. On the other hand, only 27 (40%) of 67 patients without the low activity allele had lymph node metastasis. The COMT genotype was significantly associated with clinical stage and the extent of regional lymph node metastasis of breast cancer (P<0.05). However, polymorphisms of the GSTM1 and GSTP1 gene were not associated with clinico-pathological factors. Our findings suggest that the allele encoding for low activity COMT may contribute to the progression of breast cancer.
Similar articles
- An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD. Lavigne JA, et al. Cancer Res. 1997 Dec 15;57(24):5493-7. Cancer Res. 1997. PMID: 9407957 - Increased formation of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes.
Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, Watanabe M, Hibi T, Kitajima M. Matsui A, et al. Cancer Lett. 2000 Apr 3;151(1):87-95. doi: 10.1016/s0304-3835(99)00424-3. Cancer Lett. 2000. PMID: 10766427 - Glutathione S-transferases M1, T1, and P1 and breast cancer.
Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D. Millikan R, et al. Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):567-73. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10868690 - Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
Sazci A, Ergul E, Utkan NZ, Canturk NZ, Kaya G. Sazci A, et al. Toxicology. 2004 Nov 15;204(2-3):197-202. doi: 10.1016/j.tox.2004.06.026. Toxicology. 2004. PMID: 15388245 - Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
Goodman JE, Lavigne JA, Hengstler JG, Tanner B, Helzlsouer KJ, Yager JD. Goodman JE, et al. Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1373-6. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11142424
Cited by
- Genetic Polymorphisms as Predictors of Survival in Breast Cancer: Future Lessons in Historical Data.
Leitão M, Lopes S, Pereira D, Medeiros R, Vieira C. Leitão M, et al. Cureus. 2022 Jan 19;14(1):e21410. doi: 10.7759/cureus.21410. eCollection 2022 Jan. Cureus. 2022. PMID: 35198317 Free PMC article. - No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.
Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Phipps AI, David SP, Hsu L, Harrison TA, Hutter CM, Duggan DJ, White E, Chan AT, Peters U. Passarelli MN, et al. Menopause. 2014 Apr;21(4):415-20. doi: 10.1097/GME.0b013e31829e498d. Menopause. 2014. PMID: 23880798 Free PMC article. - Chemical reaction of soybean flavonoids with DNA: a computational study using the implicit solvent model.
Abdallah HH, Mavri J, Repič M, Lee VS, Wahab HA. Abdallah HH, et al. Int J Mol Sci. 2012;13(2):1269-1283. doi: 10.3390/ijms13021269. Epub 2012 Jan 25. Int J Mol Sci. 2012. PMID: 22408390 Free PMC article. - Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG.
Landis-Piwowar K, Chen D, Chan TH, Dou QP. Landis-Piwowar K, et al. Oncol Rep. 2010 Aug;24(2):563-9. doi: 10.3892/or_00000893. Oncol Rep. 2010. PMID: 20596647 Free PMC article. - Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models.
Sei Y, Li Z, Song J, Ren-Patterson R, Tunbridge EM, Iizuka Y, Inoue M, Alfonso BT, Beltaifa S, Nakai Y, Kolachana BS, Chen J, Weinberger DR. Sei Y, et al. PLoS One. 2010 May 24;5(5):e10789. doi: 10.1371/journal.pone.0010789. PLoS One. 2010. PMID: 20520724 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous